Life Sciences

U.S regulators said Monday that the surgery required to implant Boston Scientific's anti-stroke device might reduce its effectiveness and said more careful review is needed before making an approval decision.

Sunovion Pharmaceuticals reported positive late-stage test results for a new drug as both an add-on and standalone treatment for seizures associated with epilepsy.

With one of the highest traffic death rates in the Western Hemisphere, Brazil recently took a bold step by requiring all professional drivers to pass a hair drug test when they apply for license renewals every five years. Effective Jan. 1, the Brazilian federal government hopes the law will act as a powerful deterrent to drivers, many of whom transport goods on 18-wheelers on Brazilian highways. By requiring hair testing instead of less-sensitive urinalysis, more professional drivers who use drugs and alcohol habitually will be prevented from renewing licenses, keeping the roads safer.

Bedford-based Hologic, Inc. which has operations in Marlborough, announced it has named Stephen P. MacMillan as its new president and CEO.

Ayer-based Cambrooke Foods, which provides medically appropriate foods to people with metabolic disorders, announced Wednesday it has formally changed its name to Cambrooke Therapeutics.

A lawsuit has accused Abbott Laboratories and its spinoff AbbVie of failing to provide legally required discounts for HIV drugs, resulting in the AIDS Healthcare Foundation (AHF) being overcharged by more than $2 million between 2005 and 2013.

Oxford Immunotec Global PLC, a medical diagnostic company with U.S. headquarters in Marlborough, has raised $62.8 million through an initial public offering of stock that closed Monday.

HeartWare International of Framingham has bought a New Jersey-based medical device manufacturer in a deal that could wind up being worth $350 million.

Jon Delli Priscoli looked to Cambridge for inspiration as he sought to make his mark in MetroWest.The...

Parcell Laboratories, a Natick-based provider of stem cell therapeutics, announced it has received a patent on its Early Lineage Adult (ELA) stem cell platform.